Literature DB >> 11707307

Caenorhabditis elegans: how good a model for veterinary parasites?

T G Geary1, D P Thompson.   

Abstract

The organism about which most is known on a molecular level is a nematode, the free-living organism Caenorhabditis elegans. This organism has served as a reasonable model for the discovery of anthelmintic drugs and for research on the mechanism of action of anthelmintics. Useful information on mechanisms of anthelmintic resistance has also been obtained from studies on C. elegans. Unfortunately, there has not been a large-scale extension of genetic techniques developed in C. elegans to research on parasitic species of veterinary (or human) parasites. Much can be learned about the essentials of nematode biology by studying C. elegans, but discovering the basic biology of nematode parasitism can only be gained through comparative studies on multiple parasitic species.

Entities:  

Mesh:

Year:  2001        PMID: 11707307     DOI: 10.1016/s0304-4017(01)00562-3

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  28 in total

Review 1.  Monoaminergic signaling as a target for anthelmintic drug discovery: receptor conservation among the free-living and parasitic nematodes.

Authors:  Richard Komuniecki; Wen Jing Law; Aaron Jex; Peter Geldhof; John Gray; Bruce Bamber; Robin B Gasser
Journal:  Mol Biochem Parasitol       Date:  2012-02-11       Impact factor: 1.759

2.  Modeling Host-Microbiome Interactions in Caenorhabditis elegans.

Authors:  Teklu K Gerbaba; Luke Green-Harrison; Andre G Buret
Journal:  J Nematol       Date:  2017-12       Impact factor: 1.402

3.  An insect pathogenic symbiosis between a Caenorhabditis and Serratia.

Authors:  Eyaulem Abebe; Feseha Abebe-Akele; Julie Morrison; Vaughn Cooper; W Kelley Thomas
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

4.  Investigation of anthelmintic activity of the acetone extract and constituents of Typha capensis against animal parasitic Haemonchus contortus and free-living Caenorhabditis elegans.

Authors:  Moise Ondua; Emmanuel Mfotie Njoya; Muna Ali Abdalla; Lyndy J McGaw
Journal:  Parasitol Res       Date:  2021-08-23       Impact factor: 2.289

5.  The new anthelmintic tribendimidine is an L-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist.

Authors:  Yan Hu; Shu-Hua Xiao; Raffi V Aroian
Journal:  PLoS Negl Trop Dis       Date:  2009-08-11

6.  Nematocidal activity of nitazoxanide in laboratory models.

Authors:  F Fonseca-Salamanca; M M Martínez-Grueiro; A R Martínez-Fernández
Journal:  Parasitol Res       Date:  2003-09-12       Impact factor: 2.289

7.  Are Caenorhabditis elegans receptors useful targets for drug discovery: pharmacological comparison of tyramine receptors with high identity from C. elegans (TYRA-2) and Brugia malayi (Bm4).

Authors:  Katherine A Smith; Elizabeth B Rex; Richard W Komuniecki
Journal:  Mol Biochem Parasitol       Date:  2007-04-13       Impact factor: 1.759

8.  Quantitative Detection of Double-Stranded RNA-Mediated Gene Silencing of Parasitism Genes in Heterodera glycines.

Authors:  Serenella A Sukno; Jamie McCuiston; Mui-Yun Wong; Xiaohong Wang; Michael R Thon; Richard Hussey; Thomas Baum; Eric Davis
Journal:  J Nematol       Date:  2007-06       Impact factor: 1.402

9.  An ultra high-throughput, whole-animal screen for small molecule modulators of a specific genetic pathway in Caenorhabditis elegans.

Authors:  Chi K Leung; Ying Wang; Siobhan Malany; Andrew Deonarine; Kevin Nguyen; Stefan Vasile; Keith P Choe
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

10.  Helminth secretome database (HSD): a collection of helminth excretory/secretory proteins predicted from expressed sequence tags (ESTs).

Authors:  Gagan Garg; Shoba Ranganathan
Journal:  BMC Genomics       Date:  2012-12-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.